Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.85877883 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.85877883 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.66607793 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.66607793 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.01543889 |
6 | myofibril assembly (GO:0030239) | 5.99023793 |
7 | actin-myosin filament sliding (GO:0033275) | 5.97839336 |
8 | muscle filament sliding (GO:0030049) | 5.97839336 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73001740 |
10 | glyoxylate metabolic process (GO:0046487) | 5.56173600 |
11 | kynurenine metabolic process (GO:0070189) | 5.46960983 |
12 | sarcomere organization (GO:0045214) | 5.35372459 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.35134205 |
14 | tryptophan catabolic process (GO:0006569) | 5.31268621 |
15 | indole-containing compound catabolic process (GO:0042436) | 5.31268621 |
16 | indolalkylamine catabolic process (GO:0046218) | 5.31268621 |
17 | lysine metabolic process (GO:0006553) | 5.30431065 |
18 | lysine catabolic process (GO:0006554) | 5.30431065 |
19 | bile acid biosynthetic process (GO:0006699) | 5.21521927 |
20 | cardiac myofibril assembly (GO:0055003) | 5.12353276 |
21 | cysteine metabolic process (GO:0006534) | 5.05206790 |
22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04374044 |
23 | tryptophan metabolic process (GO:0006568) | 5.00787385 |
24 | sulfur amino acid catabolic process (GO:0000098) | 4.99718817 |
25 | actin-mediated cell contraction (GO:0070252) | 4.94683110 |
26 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.91952548 |
27 | urea cycle (GO:0000050) | 4.90624048 |
28 | urea metabolic process (GO:0019627) | 4.90624048 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.78647305 |
30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.77333792 |
31 | negative regulation of fibrinolysis (GO:0051918) | 4.76300891 |
32 | cellular ketone body metabolic process (GO:0046950) | 4.67552943 |
33 | amino-acid betaine metabolic process (GO:0006577) | 4.66492712 |
34 | regulation of relaxation of muscle (GO:1901077) | 4.65737774 |
35 | serine family amino acid catabolic process (GO:0009071) | 4.63256052 |
36 | protein carboxylation (GO:0018214) | 4.61908808 |
37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.61908808 |
38 | complement activation, alternative pathway (GO:0006957) | 4.56099927 |
39 | regulation of skeletal muscle contraction (GO:0014819) | 4.55835113 |
40 | nitrogen cycle metabolic process (GO:0071941) | 4.54780064 |
41 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.53300821 |
42 | regulation of fibrinolysis (GO:0051917) | 4.52017313 |
43 | regulation of protein activation cascade (GO:2000257) | 4.44348001 |
44 | bile acid metabolic process (GO:0008206) | 4.42759151 |
45 | alpha-amino acid catabolic process (GO:1901606) | 4.37633434 |
46 | aromatic amino acid family metabolic process (GO:0009072) | 4.36003741 |
47 | 2-oxoglutarate metabolic process (GO:0006103) | 4.35722170 |
48 | fatty acid beta-oxidation (GO:0006635) | 4.32819122 |
49 | homocysteine metabolic process (GO:0050667) | 4.31569643 |
50 | acylglycerol homeostasis (GO:0055090) | 4.26840773 |
51 | triglyceride homeostasis (GO:0070328) | 4.26840773 |
52 | regulation of sequestering of triglyceride (GO:0010889) | 4.25231659 |
53 | short-chain fatty acid metabolic process (GO:0046459) | 4.22453352 |
54 | regulation of cholesterol esterification (GO:0010872) | 4.18596952 |
55 | reverse cholesterol transport (GO:0043691) | 4.18324499 |
56 | carnitine transmembrane transport (GO:1902603) | 4.17718804 |
57 | cardiac muscle hypertrophy (GO:0003300) | 4.17290043 |
58 | ethanol oxidation (GO:0006069) | 4.17137082 |
59 | tyrosine metabolic process (GO:0006570) | 4.14981029 |
60 | regulation of complement activation (GO:0030449) | 4.14666099 |
61 | aspartate family amino acid catabolic process (GO:0009068) | 4.14442444 |
62 | protein-lipid complex remodeling (GO:0034368) | 4.14266741 |
63 | macromolecular complex remodeling (GO:0034367) | 4.14266741 |
64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.14266741 |
65 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.12896385 |
66 | striated muscle contraction (GO:0006941) | 4.12475479 |
67 | cellular amino acid catabolic process (GO:0009063) | 4.11956340 |
68 | fatty acid oxidation (GO:0019395) | 4.10596899 |
69 | fatty acid catabolic process (GO:0009062) | 4.05712774 |
70 | ketone body metabolic process (GO:1902224) | 4.03448250 |
71 | plasma lipoprotein particle clearance (GO:0034381) | 4.02478408 |
72 | lipid oxidation (GO:0034440) | 4.02268290 |
73 | cardiac muscle contraction (GO:0060048) | 4.01351472 |
74 | carnitine transport (GO:0015879) | 4.00923170 |
75 | amino-acid betaine transport (GO:0015838) | 4.00923170 |
76 | glutamate metabolic process (GO:0006536) | 3.99213647 |
77 | skeletal muscle contraction (GO:0003009) | 3.98943654 |
78 | monocarboxylic acid catabolic process (GO:0072329) | 3.97184039 |
79 | cellular modified amino acid catabolic process (GO:0042219) | 3.95551796 |
80 | striated muscle hypertrophy (GO:0014897) | 3.95430796 |
81 | negative regulation of sterol transport (GO:0032372) | 3.94576849 |
82 | negative regulation of cholesterol transport (GO:0032375) | 3.94576849 |
83 | * acetyl-CoA metabolic process (GO:0006084) | 3.94216499 |
84 | phospholipid efflux (GO:0033700) | 3.94085533 |
85 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90480695 |
86 | glycine metabolic process (GO:0006544) | 3.85758373 |
87 | valine metabolic process (GO:0006573) | 3.85731891 |
88 | organic acid catabolic process (GO:0016054) | 3.85630346 |
89 | carboxylic acid catabolic process (GO:0046395) | 3.85630346 |
90 | actin filament-based movement (GO:0030048) | 3.83623935 |
91 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.83462126 |
92 | actomyosin structure organization (GO:0031032) | 3.81972952 |
93 | carnitine metabolic process (GO:0009437) | 3.81741619 |
94 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.79850157 |
95 | fatty acid transmembrane transport (GO:1902001) | 3.78760464 |
96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.76127987 |
97 | creatine metabolic process (GO:0006600) | 3.75711224 |
98 | serine family amino acid metabolic process (GO:0009069) | 3.74476478 |
99 | indolalkylamine metabolic process (GO:0006586) | 3.74171721 |
100 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.73042179 |
101 | muscle hypertrophy (GO:0014896) | 3.70298278 |
102 | bile acid and bile salt transport (GO:0015721) | 3.70066627 |
103 | benzene-containing compound metabolic process (GO:0042537) | 3.69820030 |
104 | cellular glucuronidation (GO:0052695) | 3.69783529 |
105 | response to inactivity (GO:0014854) | 3.69765719 |
106 | positive regulation of lipid catabolic process (GO:0050996) | 3.69553958 |
107 | skeletal muscle adaptation (GO:0043501) | 3.68309231 |
108 | phospholipid homeostasis (GO:0055091) | 3.62592348 |
109 | * coenzyme catabolic process (GO:0009109) | 3.61490201 |
110 | branched-chain amino acid catabolic process (GO:0009083) | 3.60899073 |
111 | adult heart development (GO:0007512) | 3.58815910 |
112 | imidazole-containing compound metabolic process (GO:0052803) | 3.57418187 |
113 | amine catabolic process (GO:0009310) | 3.56185124 |
114 | cellular biogenic amine catabolic process (GO:0042402) | 3.56185124 |
115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53031820 |
116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53031820 |
117 | cholesterol efflux (GO:0033344) | 3.52667929 |
118 | carnitine shuttle (GO:0006853) | 3.52182771 |
119 | response to muscle activity (GO:0014850) | 3.51674415 |
120 | drug catabolic process (GO:0042737) | 3.51280889 |
121 | arginine metabolic process (GO:0006525) | 3.49483633 |
122 | quaternary ammonium group transport (GO:0015697) | 3.47586694 |
123 | negative regulation of lipase activity (GO:0060192) | 3.47460689 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 3.46595928 |
125 | aldehyde catabolic process (GO:0046185) | 3.44365954 |
126 | plasma lipoprotein particle assembly (GO:0034377) | 3.43683286 |
127 | regulation of cholesterol metabolic process (GO:0090181) | 3.42645670 |
128 | serine family amino acid biosynthetic process (GO:0009070) | 3.40548754 |
129 | branched-chain amino acid metabolic process (GO:0009081) | 3.40178605 |
130 | cholesterol homeostasis (GO:0042632) | 3.40034745 |
131 | regulation of sarcomere organization (GO:0060297) | 3.34811263 |
132 | sterol homeostasis (GO:0055092) | 3.34427020 |
133 | muscle contraction (GO:0006936) | 3.34032444 |
134 | striated muscle adaptation (GO:0014888) | 3.31888011 |
135 | low-density lipoprotein particle remodeling (GO:0034374) | 3.31496768 |
136 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.29737790 |
137 | regulation of actin filament-based movement (GO:1903115) | 3.29671467 |
138 | striated muscle atrophy (GO:0014891) | 3.28921224 |
139 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.26256277 |
140 | cardiac muscle adaptation (GO:0014887) | 3.15767551 |
141 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.15767551 |
142 | muscle hypertrophy in response to stress (GO:0003299) | 3.15767551 |
143 | regulation of cell communication by electrical coupling (GO:0010649) | 3.15443895 |
144 | muscle system process (GO:0003012) | 3.12621135 |
145 | * regulation of fatty acid oxidation (GO:0046320) | 3.07620207 |
146 | regulation of striated muscle contraction (GO:0006942) | 3.07080839 |
147 | exogenous drug catabolic process (GO:0042738) | 3.03905758 |
148 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.99342733 |
149 | regulation of membrane repolarization (GO:0060306) | 2.98078102 |
150 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.97728394 |
151 | positive regulation of cation channel activity (GO:2001259) | 2.95576417 |
152 | cardiac muscle cell development (GO:0055013) | 2.89935462 |
153 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.89126435 |
154 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.87535766 |
155 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.85360295 |
156 | response to epinephrine (GO:0071871) | 2.85329029 |
157 | regulation of the force of heart contraction (GO:0002026) | 2.84970526 |
158 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.84501037 |
159 | epoxygenase P450 pathway (GO:0019373) | 2.84346146 |
160 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.83202437 |
161 | biotin metabolic process (GO:0006768) | 2.81434393 |
162 | cellular response to epinephrine stimulus (GO:0071872) | 2.80709361 |
163 | macroautophagy (GO:0016236) | 2.78761708 |
164 | muscle fiber development (GO:0048747) | 2.77195481 |
165 | muscle tissue morphogenesis (GO:0060415) | 2.76123054 |
166 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.73558867 |
167 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.71810060 |
168 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69409502 |
169 | cardiac cell development (GO:0055006) | 2.66962190 |
170 | muscle atrophy (GO:0014889) | 2.64727609 |
171 | muscle adaptation (GO:0043500) | 2.64295233 |
172 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.59984698 |
173 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.59984698 |
174 | response to caffeine (GO:0031000) | 2.53799146 |
175 | flavonoid metabolic process (GO:0009812) | 2.51011298 |
176 | myotube cell development (GO:0014904) | 2.50777475 |
177 | establishment of protein localization to Golgi (GO:0072600) | 2.50746334 |
178 | mannose metabolic process (GO:0006013) | 2.47108723 |
179 | positive regulation of myoblast differentiation (GO:0045663) | 2.43245909 |
180 | regulation of cardiac muscle contraction (GO:0055117) | 2.39827383 |
181 | * positive regulation of fatty acid oxidation (GO:0046321) | 2.39377446 |
182 | plasma membrane repair (GO:0001778) | 2.39268827 |
183 | relaxation of cardiac muscle (GO:0055119) | 2.38790365 |
184 | skeletal muscle fiber development (GO:0048741) | 2.37161634 |
185 | dicarboxylic acid catabolic process (GO:0043649) | 2.36417268 |
186 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.35948404 |
187 | striated muscle cell development (GO:0055002) | 2.35890303 |
188 | alanine transport (GO:0032328) | 2.35593646 |
189 | regulation of myoblast differentiation (GO:0045661) | 2.34981929 |
190 | glycogen catabolic process (GO:0005980) | 2.34952825 |
191 | interkinetic nuclear migration (GO:0022027) | 2.34846445 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.62557497 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66638525 |
3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.41902078 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.92705415 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.57309752 |
6 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.95306532 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.86007175 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.33556608 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.77765560 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24583350 |
11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.01623002 |
12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.18495717 |
13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07008292 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9738425 |
15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99682548 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90545645 |
17 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90525157 |
18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.88670904 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86333115 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72907804 |
21 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.64804265 |
22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63233739 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61450780 |
24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55553293 |
25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52584897 |
26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52007229 |
27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48170498 |
28 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46264802 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45995607 |
30 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.45850905 |
31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35706475 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35052326 |
33 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.34607432 |
34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34077412 |
35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28904258 |
36 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26242799 |
37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25216783 |
38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23695618 |
39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.22596274 |
40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21053298 |
41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21033920 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19432219 |
43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17648233 |
44 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17290539 |
45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16667049 |
46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16189834 |
47 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16092125 |
48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13178836 |
49 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12931420 |
50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10065424 |
51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09807989 |
52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09747754 |
53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05466017 |
54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04462237 |
55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04208076 |
56 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03503770 |
57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03221908 |
58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02936840 |
59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00592117 |
60 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00131259 |
61 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98312060 |
62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98312060 |
63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98044512 |
64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97046939 |
65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96800387 |
66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96800387 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96184832 |
68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96003919 |
69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95579805 |
70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94549707 |
71 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94185131 |
72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94118727 |
73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93911938 |
74 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93794028 |
75 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92821208 |
76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92172384 |
77 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91746294 |
78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90401509 |
79 | AR_19668381_ChIP-Seq_PC3_Human | 0.89651027 |
80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89569216 |
81 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89472412 |
82 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.87665924 |
83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86680397 |
84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86327806 |
85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86296804 |
86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86184186 |
87 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85805869 |
88 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85377142 |
89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84784305 |
90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84768807 |
91 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84114948 |
92 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.83955845 |
93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83314624 |
94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83063566 |
95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82857605 |
96 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82041349 |
97 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.81285270 |
98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81277709 |
99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80914052 |
100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80821025 |
101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80442270 |
102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79886999 |
103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79729498 |
104 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79492387 |
105 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79174161 |
106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76978152 |
107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76926053 |
108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76442206 |
109 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.76353969 |
110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76047917 |
111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75725209 |
112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75016717 |
113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74800969 |
114 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.74198963 |
115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74052782 |
116 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.73904185 |
117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73305709 |
118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71986711 |
119 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71125953 |
120 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70802748 |
121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70056556 |
122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70046657 |
123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.69278250 |
124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69143778 |
125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67749525 |
126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66384760 |
127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.65999740 |
128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65565747 |
129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64731519 |
130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62162707 |
131 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61399648 |
132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59368191 |
133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.59351112 |
134 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58231794 |
135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57480610 |
136 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.56345077 |
137 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.56319782 |
138 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55642835 |
139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55428565 |
140 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54546344 |
141 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.54017354 |
142 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.53699779 |
143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.53688361 |
144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.53604560 |
145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53480819 |
146 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.53453401 |
147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53215891 |
148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.53072139 |
149 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.53028563 |
150 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52892368 |
151 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.52712751 |
152 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.52363929 |
153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.52268123 |
154 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.51562286 |
155 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.50282479 |
156 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49456478 |
157 | P68_20966046_ChIP-Seq_HELA_Human | 0.49408245 |
158 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.49218439 |
159 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.49218439 |
160 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.49178407 |
161 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48304206 |
162 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48101196 |
163 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.47676829 |
164 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47307245 |
165 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46790554 |
166 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46654332 |
167 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46467441 |
168 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.46463293 |
169 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46339640 |
170 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.46254558 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.45379065 |
2 | MP0005360_urolithiasis | 6.61986687 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.69211407 |
4 | MP0005365_abnormal_bile_salt | 5.62785792 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.42710132 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.94934073 |
7 | MP0004145_abnormal_muscle_electrophysio | 3.85676661 |
8 | MP0003252_abnormal_bile_duct | 3.49062041 |
9 | MP0010329_abnormal_lipoprotein_level | 3.32993257 |
10 | MP0009840_abnormal_foam_cell | 3.15633060 |
11 | MP0005083_abnormal_biliary_tract | 3.02005288 |
12 | MP0005332_abnormal_amino_acid | 2.77772292 |
13 | MP0003195_calcinosis | 2.72746210 |
14 | MP0002837_dystrophic_cardiac_calcinosis | 2.69330986 |
15 | MP0001666_abnormal_nutrient_absorption | 2.56793969 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.37046947 |
17 | MP0004233_abnormal_muscle_weight | 2.28640223 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.17343137 |
19 | MP0004484_altered_response_of | 2.16674931 |
20 | MP0000609_abnormal_liver_physiology | 2.05968241 |
21 | MP0004510_myositis | 2.03004170 |
22 | MP0005319_abnormal_enzyme/_coenzyme | 1.89751603 |
23 | MP0005369_muscle_phenotype | 1.87634462 |
24 | MP0004130_abnormal_muscle_cell | 1.83861357 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.76865044 |
26 | MP0006036_abnormal_mitochondrial_physio | 1.73061229 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.72950482 |
28 | MP0003646_muscle_fatigue | 1.70923701 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68217764 |
30 | MP0003868_abnormal_feces_composition | 1.67187703 |
31 | MP0002127_abnormal_cardiovascular_syste | 1.67072417 |
32 | MP0005670_abnormal_white_adipose | 1.55059024 |
33 | MP0003045_fibrosis | 1.50228326 |
34 | MP0001764_abnormal_homeostasis | 1.49688517 |
35 | MP0000750_abnormal_muscle_regeneration | 1.48384023 |
36 | MP0003879_abnormal_hair_cell | 1.44356736 |
37 | MP0009643_abnormal_urine_homeostasis | 1.42954116 |
38 | MP0005451_abnormal_body_composition | 1.41874684 |
39 | MP0004085_abnormal_heartbeat | 1.37694225 |
40 | MP0002108_abnormal_muscle_morphology | 1.34616863 |
41 | MP0003656_abnormal_erythrocyte_physiolo | 1.28185000 |
42 | MP0005330_cardiomyopathy | 1.25109284 |
43 | MP0003186_abnormal_redox_activity | 1.21239630 |
44 | MP0000013_abnormal_adipose_tissue | 1.17335269 |
45 | MP0005666_abnormal_adipose_tissue | 1.16421307 |
46 | MP0002971_abnormal_brown_adipose | 1.14130333 |
47 | MP0004036_abnormal_muscle_relaxation | 1.10319129 |
48 | * MP0002078_abnormal_glucose_homeostasis | 1.09720136 |
49 | MP0000751_myopathy | 1.08941836 |
50 | MP0009780_abnormal_chondrocyte_physiolo | 1.08360130 |
51 | MP0000598_abnormal_liver_morphology | 1.08336180 |
52 | MP0003705_abnormal_hypodermis_morpholog | 1.08332677 |
53 | MP0009697_abnormal_copulation | 1.07163357 |
54 | MP0002269_muscular_atrophy | 1.02971785 |
55 | MP0000749_muscle_degeneration | 1.01614185 |
56 | MP0005636_abnormal_mineral_homeostasis | 1.01406694 |
57 | MP0005535_abnormal_body_temperature | 1.01363416 |
58 | MP0000003_abnormal_adipose_tissue | 1.01257350 |
59 | MP0006035_abnormal_mitochondrial_morpho | 0.98432982 |
60 | MP0004084_abnormal_cardiac_muscle | 0.95729266 |
61 | MP0000604_amyloidosis | 0.94946454 |
62 | MP0010368_abnormal_lymphatic_system | 0.93606801 |
63 | MP0003011_delayed_dark_adaptation | 0.93264506 |
64 | MP0004215_abnormal_myocardial_fiber | 0.92068523 |
65 | MP0009642_abnormal_blood_homeostasis | 0.90869474 |
66 | MP0005334_abnormal_fat_pad | 0.90421183 |
67 | MP0003828_pulmonary_edema | 0.90063277 |
68 | MP0009763_increased_sensitivity_to | 0.89835906 |
69 | MP0005266_abnormal_metabolism | 0.89226064 |
70 | MP0005167_abnormal_blood-brain_barrier | 0.86112734 |
71 | MP0001501_abnormal_sleep_pattern | 0.85173681 |
72 | MP0008469_abnormal_protein_level | 0.83758140 |
73 | MP0004087_abnormal_muscle_fiber | 0.83504486 |
74 | MP0000569_abnormal_digit_pigmentation | 0.81754455 |
75 | MP0009764_decreased_sensitivity_to | 0.81696484 |
76 | MP0005647_abnormal_sex_gland | 0.81318265 |
77 | MP0005084_abnormal_gallbladder_morpholo | 0.80909699 |
78 | MP0005376_homeostasis/metabolism_phenot | 0.78984650 |
79 | MP0000747_muscle_weakness | 0.77196034 |
80 | MP0005220_abnormal_exocrine_pancreas | 0.76035443 |
81 | MP0004043_abnormal_pH_regulation | 0.75129497 |
82 | MP0001756_abnormal_urination | 0.73122381 |
83 | MP0005448_abnormal_energy_balance | 0.72214528 |
84 | MP0003329_amyloid_beta_deposits | 0.71543692 |
85 | MP0002876_abnormal_thyroid_physiology | 0.71358391 |
86 | MP0000266_abnormal_heart_morphology | 0.69075403 |
87 | MP0004924_abnormal_behavior | 0.68172245 |
88 | MP0005386_behavior/neurological_phenoty | 0.68172245 |
89 | MP0005385_cardiovascular_system_phenoty | 0.68057759 |
90 | MP0001544_abnormal_cardiovascular_syste | 0.68057759 |
91 | MP0000733_abnormal_muscle_development | 0.68003721 |
92 | MP0008004_abnormal_stomach_pH | 0.66122193 |
93 | MP0001664_abnormal_digestion | 0.65982826 |
94 | MP0002638_abnormal_pupillary_reflex | 0.65541941 |
95 | MP0000230_abnormal_systemic_arterial | 0.65241924 |
96 | MP0005620_abnormal_muscle_contractility | 0.65195613 |
97 | MP0002972_abnormal_cardiac_muscle | 0.64596192 |
98 | MP0003878_abnormal_ear_physiology | 0.64539185 |
99 | MP0005377_hearing/vestibular/ear_phenot | 0.64539185 |
100 | MP0004142_abnormal_muscle_tone | 0.64460573 |
101 | MP0004185_abnormal_adipocyte_glucose | 0.64170986 |
102 | MP0005375_adipose_tissue_phenotype | 0.64004179 |
103 | MP0005058_abnormal_lysosome_morphology | 0.63871314 |
104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62683599 |
105 | MP0000470_abnormal_stomach_morphology | 0.62554881 |
106 | MP0010630_abnormal_cardiac_muscle | 0.59171864 |
107 | MP0002693_abnormal_pancreas_physiology | 0.57542632 |
108 | MP0001661_extended_life_span | 0.57029255 |
109 | MP0002909_abnormal_adrenal_gland | 0.56796452 |
110 | MP0008877_abnormal_DNA_methylation | 0.56762275 |
111 | MP0002168_other_aberrant_phenotype | 0.56625314 |
112 | MP0002822_catalepsy | 0.56621058 |
113 | MP0009765_abnormal_xenobiotic_induced | 0.56309787 |
114 | MP0008775_abnormal_heart_ventricle | 0.55633028 |
115 | MP0001984_abnormal_olfaction | 0.55453029 |
116 | MP0005452_abnormal_adipose_tissue | 0.55068782 |
117 | MP0003953_abnormal_hormone_level | 0.54919552 |
118 | MP0003690_abnormal_glial_cell | 0.54890003 |
119 | MP0006138_congestive_heart_failure | 0.54354222 |
120 | MP0009046_muscle_twitch | 0.53864180 |
121 | MP0008872_abnormal_physiological_respon | 0.53632400 |
122 | MP0003137_abnormal_impulse_conducting | 0.51651283 |
123 | MP0008961_abnormal_basal_metabolism | 0.51372797 |
124 | MP0002970_abnormal_white_adipose | 0.51134799 |
125 | MP0000015_abnormal_ear_pigmentation | 0.50911499 |
126 | MP0002332_abnormal_exercise_endurance | 0.49859558 |
127 | MP0008874_decreased_physiological_sensi | 0.49353833 |
128 | MP0009115_abnormal_fat_cell | 0.48071505 |
129 | MP0004381_abnormal_hair_follicle | 0.47743601 |
130 | MP0002136_abnormal_kidney_physiology | 0.47391570 |
131 | MP0005408_hypopigmentation | 0.46479455 |
132 | MP0002106_abnormal_muscle_physiology | 0.45820944 |
133 | MP0002254_reproductive_system_inflammat | 0.44750858 |
134 | MP0003959_abnormal_lean_body | 0.44614791 |
135 | MP0001765_abnormal_ion_homeostasis | 0.44477569 |
136 | MP0003638_abnormal_response/metabolism_ | 0.42541951 |
137 | MP0000759_abnormal_skeletal_muscle | 0.42113209 |
138 | MP0002928_abnormal_bile_duct | 0.42007874 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyporeflexia of lower limbs (HP:0002600) | 6.20478114 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.20473235 |
3 | Muscle fiber inclusion bodies (HP:0100299) | 6.09084045 |
4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.93826397 |
5 | Deep venous thrombosis (HP:0002625) | 5.86821993 |
6 | Intrahepatic cholestasis (HP:0001406) | 5.73006767 |
7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.62734995 |
8 | Nemaline bodies (HP:0003798) | 5.47775457 |
9 | Calf muscle hypertrophy (HP:0008981) | 5.39054838 |
10 | Xanthomatosis (HP:0000991) | 5.36198434 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.18890588 |
12 | Hypobetalipoproteinemia (HP:0003563) | 5.01950037 |
13 | Bundle branch block (HP:0011710) | 4.99499417 |
14 | Prolonged partial thromboplastin time (HP:0003645) | 4.95396571 |
15 | Type 1 muscle fiber predominance (HP:0003803) | 4.94856067 |
16 | Hyperlipoproteinemia (HP:0010980) | 4.81888217 |
17 | Abnormality of the calf musculature (HP:0001430) | 4.81362528 |
18 | Muscle fiber splitting (HP:0003555) | 4.70236426 |
19 | Hypoglycemic coma (HP:0001325) | 4.68545053 |
20 | * Ketosis (HP:0001946) | 4.62510567 |
21 | Hyperammonemia (HP:0001987) | 4.62370875 |
22 | EMG: myopathic abnormalities (HP:0003458) | 4.28293515 |
23 | Complement deficiency (HP:0004431) | 4.19294533 |
24 | Hyperglycinuria (HP:0003108) | 4.14156691 |
25 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.10696849 |
26 | Hyperglycinemia (HP:0002154) | 4.09808289 |
27 | Ketoacidosis (HP:0001993) | 4.07624490 |
28 | Hypolipoproteinemia (HP:0010981) | 4.04674673 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.97398542 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97398542 |
31 | Subaortic stenosis (HP:0001682) | 3.80895814 |
32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.80895814 |
33 | Hypoalphalipoproteinemia (HP:0003233) | 3.79997690 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.79258452 |
35 | Myopathic facies (HP:0002058) | 3.76942080 |
36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74231951 |
37 | Abnormality of the common coagulation pathway (HP:0010990) | 3.62803232 |
38 | Joint hemorrhage (HP:0005261) | 3.62595756 |
39 | Epidermoid cyst (HP:0200040) | 3.61843072 |
40 | Difficulty running (HP:0009046) | 3.59038715 |
41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.57374168 |
42 | Prolonged QT interval (HP:0001657) | 3.56809676 |
43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.55372378 |
44 | Areflexia of lower limbs (HP:0002522) | 3.54554548 |
45 | Atrial fibrillation (HP:0005110) | 3.54177724 |
46 | Syncope (HP:0001279) | 3.53934991 |
47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.50308809 |
48 | Frequent falls (HP:0002359) | 3.49504671 |
49 | Dicarboxylic aciduria (HP:0003215) | 3.48264839 |
50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.48264839 |
51 | Abnormality of methionine metabolism (HP:0010901) | 3.47382368 |
52 | EMG: neuropathic changes (HP:0003445) | 3.43425040 |
53 | Ventricular tachycardia (HP:0004756) | 3.41465663 |
54 | Neck muscle weakness (HP:0000467) | 3.35282403 |
55 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28325255 |
56 | Heart block (HP:0012722) | 3.25694838 |
57 | Lipoatrophy (HP:0100578) | 3.24162908 |
58 | Fat malabsorption (HP:0002630) | 3.23720219 |
59 | Distal lower limb muscle weakness (HP:0009053) | 3.23095601 |
60 | Myoglobinuria (HP:0002913) | 3.20339697 |
61 | Dilated cardiomyopathy (HP:0001644) | 3.18935359 |
62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.15331204 |
63 | Primary atrial arrhythmia (HP:0001692) | 3.14458626 |
64 | Hyperventilation (HP:0002883) | 3.12896632 |
65 | Rimmed vacuoles (HP:0003805) | 3.12338628 |
66 | Ventricular fibrillation (HP:0001663) | 3.11906735 |
67 | Cerebral edema (HP:0002181) | 3.07349210 |
68 | Dysmetric saccades (HP:0000641) | 3.06101484 |
69 | Ventricular arrhythmia (HP:0004308) | 2.98742905 |
70 | Hyperbilirubinemia (HP:0002904) | 2.98682030 |
71 | Gout (HP:0001997) | 2.98355995 |
72 | Hypercholesterolemia (HP:0003124) | 2.96954546 |
73 | Supraventricular tachycardia (HP:0004755) | 2.96414485 |
74 | * Metabolic acidosis (HP:0001942) | 2.96205279 |
75 | Abnormality of serum amino acid levels (HP:0003112) | 2.96016405 |
76 | Abnormality of complement system (HP:0005339) | 2.95573750 |
77 | Abnormal atrioventricular conduction (HP:0005150) | 2.93951272 |
78 | Generalized aminoaciduria (HP:0002909) | 2.90705976 |
79 | Lethargy (HP:0001254) | 2.89010298 |
80 | Supraventricular arrhythmia (HP:0005115) | 2.85425510 |
81 | Abnormal EKG (HP:0003115) | 2.84953489 |
82 | Distal arthrogryposis (HP:0005684) | 2.83549139 |
83 | Delayed CNS myelination (HP:0002188) | 2.82379790 |
84 | Abnormality of purine metabolism (HP:0004352) | 2.75924104 |
85 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73319721 |
86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72546139 |
87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72250228 |
88 | Round ear (HP:0100830) | 2.70330603 |
89 | Clumsiness (HP:0002312) | 2.69353985 |
90 | Oligomenorrhea (HP:0000876) | 2.68777855 |
91 | Conjugated hyperbilirubinemia (HP:0002908) | 2.66716079 |
92 | Late onset (HP:0003584) | 2.65695018 |
93 | Skin nodule (HP:0200036) | 2.65443579 |
94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.64902475 |
95 | Hypoglycemic seizures (HP:0002173) | 2.63876628 |
96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.60927447 |
97 | Hyperkalemia (HP:0002153) | 2.54385482 |
98 | Exercise-induced myalgia (HP:0003738) | 2.51917823 |
99 | Right ventricular cardiomyopathy (HP:0011663) | 2.51736809 |
100 | Rhabdomyolysis (HP:0003201) | 2.51596615 |
101 | Cholelithiasis (HP:0001081) | 2.50479621 |
102 | Abnormal gallbladder morphology (HP:0012437) | 2.49766136 |
103 | Hepatic necrosis (HP:0002605) | 2.48624569 |
104 | Bulbar palsy (HP:0001283) | 2.46978094 |
105 | Scapular winging (HP:0003691) | 2.41533432 |
106 | Steatorrhea (HP:0002570) | 2.39140736 |
107 | Hepatocellular carcinoma (HP:0001402) | 2.38990329 |
108 | * Vomiting (HP:0002013) | 2.36577554 |
109 | Generalized muscle weakness (HP:0003324) | 2.35592290 |
110 | Genetic anticipation (HP:0003743) | 2.34274763 |
111 | Muscle stiffness (HP:0003552) | 2.30424177 |
112 | Atrioventricular block (HP:0001678) | 2.29170569 |
113 | Myocardial infarction (HP:0001658) | 2.25199590 |
114 | Increased connective tissue (HP:0009025) | 2.21926943 |
115 | Ulnar deviation of the wrist (HP:0003049) | 2.21689073 |
116 | Proximal tubulopathy (HP:0000114) | 2.19911932 |
117 | Myotonia (HP:0002486) | 2.19607929 |
118 | Neonatal onset (HP:0003623) | 2.19492141 |
119 | Cholecystitis (HP:0001082) | 2.16483690 |
120 | Abnormal gallbladder physiology (HP:0012438) | 2.16483690 |
121 | Muscular dystrophy (HP:0003560) | 2.15811751 |
122 | Postural instability (HP:0002172) | 2.14415527 |
123 | Acute encephalopathy (HP:0006846) | 2.14103436 |
124 | Spontaneous abortion (HP:0005268) | 2.13886085 |
125 | Pancreatitis (HP:0001733) | 2.12317630 |
126 | Hyperglycemia (HP:0003074) | 2.10743391 |
127 | Increased muscle lipid content (HP:0009058) | 2.09532818 |
128 | Reduced antithrombin III activity (HP:0001976) | 2.08781563 |
129 | Systemic lupus erythematosus (HP:0002725) | 2.08726438 |
130 | Abnormality of the foot musculature (HP:0001436) | 2.07646064 |
131 | Hyperuricemia (HP:0002149) | 2.06748014 |
132 | Increased purine levels (HP:0004368) | 2.06748014 |
133 | Left ventricular hypertrophy (HP:0001712) | 2.05175186 |
134 | Ragged-red muscle fibers (HP:0003200) | 2.04415201 |
135 | Vascular calcification (HP:0004934) | 2.03889604 |
136 | Sudden death (HP:0001699) | 2.03671131 |
137 | Exercise-induced muscle cramps (HP:0003710) | 2.03342334 |
138 | Irritability (HP:0000737) | 2.02630862 |
139 | Brushfield spots (HP:0001088) | 2.00410467 |
140 | Renal cortical cysts (HP:0000803) | 1.99816852 |
141 | Sensorimotor neuropathy (HP:0007141) | 1.98846758 |
142 | Glycosuria (HP:0003076) | 1.97800766 |
143 | Abnormality of urine glucose concentration (HP:0011016) | 1.97800766 |
144 | Malnutrition (HP:0004395) | 1.97485393 |
145 | Nausea (HP:0002018) | 1.97213150 |
146 | Mitral stenosis (HP:0001718) | 1.96397409 |
147 | Palpitations (HP:0001962) | 1.95634876 |
148 | Fetal akinesia sequence (HP:0001989) | 1.95200014 |
149 | Spastic diplegia (HP:0001264) | 1.94244231 |
150 | Abnormal cartilage morphology (HP:0002763) | 1.92864755 |
151 | Abnormality of the gallbladder (HP:0005264) | 1.92457031 |
152 | Foot dorsiflexor weakness (HP:0009027) | 1.91975989 |
153 | Protruding tongue (HP:0010808) | 1.91351686 |
154 | Acanthocytosis (HP:0001927) | 1.91112396 |
155 | Steppage gait (HP:0003376) | 1.90293217 |
156 | Progressive cerebellar ataxia (HP:0002073) | 1.89354730 |
157 | Difficulty walking (HP:0002355) | 1.88905450 |
158 | Amyloidosis (HP:0011034) | 1.86935700 |
159 | Asymmetric septal hypertrophy (HP:0001670) | 1.84294318 |
160 | Abnormality of proline metabolism (HP:0010907) | 1.84029529 |
161 | Hydroxyprolinuria (HP:0003080) | 1.84029529 |
162 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.83639301 |
163 | Hypochromic microcytic anemia (HP:0004840) | 1.83289925 |
164 | Facial diplegia (HP:0001349) | 1.83261735 |
165 | Methylmalonic aciduria (HP:0012120) | 1.81720906 |
166 | Cardiovascular calcification (HP:0011915) | 1.80014504 |
167 | Enlarged kidneys (HP:0000105) | 1.79625163 |
168 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.78086992 |
169 | Acute hepatic failure (HP:0006554) | 1.77662270 |
170 | Gowers sign (HP:0003391) | 1.77638102 |
171 | Proximal amyotrophy (HP:0007126) | 1.74054613 |
172 | Gaze-evoked nystagmus (HP:0000640) | 1.70809716 |
173 | Intellectual disability, progressive (HP:0006887) | 1.69772338 |
174 | Hip contracture (HP:0003273) | 1.64087801 |
175 | Abnormality of the renal cortex (HP:0011035) | 1.61653485 |
176 | Decreased circulating renin level (HP:0003351) | 1.61510248 |
177 | Double outlet right ventricle (HP:0001719) | 1.61457907 |
178 | Congenital malformation of the right heart (HP:0011723) | 1.61457907 |
179 | Hypoplastic ischia (HP:0003175) | 1.57902750 |
180 | Nonprogressive disorder (HP:0003680) | 1.57184824 |
181 | Abnormality of potassium homeostasis (HP:0011042) | 1.55446433 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.12998450 |
2 | ERN1 | 3.82776076 |
3 | TRIB3 | 3.41814762 |
4 | FGFR4 | 3.17523785 |
5 | SIK1 | 3.17331673 |
6 | PKN2 | 3.09904701 |
7 | INSRR | 2.55847140 |
8 | TTN | 2.52062810 |
9 | OBSCN | 2.18104494 |
10 | FLT3 | 2.15495092 |
11 | AKT3 | 2.06484244 |
12 | PDK3 | 1.98774618 |
13 | PDK4 | 1.98774618 |
14 | PINK1 | 1.96328462 |
15 | TAOK3 | 1.88570973 |
16 | MAP2K4 | 1.77982543 |
17 | PIK3CG | 1.76007219 |
18 | PHKG2 | 1.70013940 |
19 | PHKG1 | 1.70013940 |
20 | MAP2K3 | 1.63632770 |
21 | MYLK | 1.55889445 |
22 | TIE1 | 1.53733221 |
23 | MAP3K7 | 1.43029182 |
24 | SGK2 | 1.42107383 |
25 | MAPK11 | 1.40275829 |
26 | LMTK2 | 1.33717959 |
27 | KDR | 1.27285882 |
28 | ERBB4 | 1.24173914 |
29 | MAP2K7 | 1.21961074 |
30 | PTK6 | 1.21831505 |
31 | MARK3 | 1.20429592 |
32 | NEK9 | 1.18439527 |
33 | TYK2 | 1.18227476 |
34 | PRKAA2 | 1.17242140 |
35 | TRPM7 | 1.16990536 |
36 | MARK2 | 1.14222719 |
37 | MAPK12 | 1.12448249 |
38 | EEF2K | 1.11491481 |
39 | SGK494 | 1.10425803 |
40 | SGK223 | 1.10425803 |
41 | CAMK1 | 1.08554530 |
42 | NEK1 | 1.07438484 |
43 | PDK2 | 1.06912664 |
44 | MST1R | 1.02607212 |
45 | CDC42BPA | 1.02561300 |
46 | PIK3CA | 1.02508132 |
47 | NLK | 1.01741690 |
48 | JAK2 | 1.00338106 |
49 | ABL2 | 1.00086275 |
50 | TNK2 | 0.99658058 |
51 | DAPK2 | 0.98408936 |
52 | JAK1 | 0.97425429 |
53 | EPHB1 | 0.97174343 |
54 | MAPK15 | 0.95236388 |
55 | TBK1 | 0.87636710 |
56 | PRKAA1 | 0.87234709 |
57 | RIPK1 | 0.86231432 |
58 | GRK1 | 0.85416209 |
59 | BLK | 0.84379175 |
60 | ACVR1B | 0.84189056 |
61 | MAP3K10 | 0.84023415 |
62 | RPS6KA6 | 0.83861692 |
63 | TGFBR2 | 0.82790179 |
64 | MAP3K11 | 0.79577127 |
65 | CAMK1D | 0.78060334 |
66 | PDPK1 | 0.76552683 |
67 | RPS6KC1 | 0.74946905 |
68 | RPS6KL1 | 0.74946905 |
69 | MAP2K6 | 0.73420045 |
70 | WNK4 | 0.72431342 |
71 | MAP3K3 | 0.72225116 |
72 | MARK1 | 0.69941576 |
73 | PRKACG | 0.68114712 |
74 | WNK1 | 0.67672956 |
75 | STK38 | 0.67647494 |
76 | MUSK | 0.67396719 |
77 | MAPK4 | 0.65355359 |
78 | RPS6KA2 | 0.65219075 |
79 | GRK6 | 0.63983199 |
80 | RET | 0.62337722 |
81 | MAP3K1 | 0.60519249 |
82 | MAP3K4 | 0.59847797 |
83 | HIPK2 | 0.59152220 |
84 | KSR2 | 0.58970787 |
85 | MAP3K5 | 0.58914917 |
86 | CAMK2G | 0.58656163 |
87 | PRKD1 | 0.58281016 |
88 | PDK1 | 0.58109843 |
89 | PAK3 | 0.56816053 |
90 | PRKD2 | 0.56578985 |
91 | FGFR2 | 0.55591445 |
92 | STK11 | 0.55232617 |
93 | MAP4K1 | 0.54753136 |
94 | SGK1 | 0.54280003 |
95 | FRK | 0.50594698 |
96 | PRKG1 | 0.50545305 |
97 | MAP2K1 | 0.50274574 |
98 | MELK | 0.49373232 |
99 | MAPK13 | 0.48682512 |
100 | FGFR3 | 0.48636333 |
101 | CDK12 | 0.47611241 |
102 | ROCK1 | 0.46780599 |
103 | PDGFRA | 0.46658482 |
104 | RPS6KB1 | 0.45366596 |
105 | PRKCZ | 0.43344671 |
106 | SGK3 | 0.42308853 |
107 | LRRK2 | 0.41858475 |
108 | LATS1 | 0.40421487 |
109 | NME2 | 0.40409200 |
110 | IKBKE | 0.40065488 |
111 | ZAP70 | 0.39776046 |
112 | CAMK4 | 0.39305011 |
113 | ITK | 0.39090526 |
114 | WNK3 | 0.38879756 |
115 | ICK | 0.38743860 |
116 | CSK | 0.38700848 |
117 | DAPK3 | 0.38311641 |
118 | PRKCH | 0.37927026 |
119 | BTK | 0.37623122 |
120 | RPS6KA3 | 0.37486587 |
121 | CHUK | 0.37448000 |
122 | SYK | 0.37444842 |
123 | GSK3A | 0.37379987 |
124 | DYRK1B | 0.36555724 |
125 | ADRBK1 | 0.36526994 |
126 | NME1 | 0.36032564 |
127 | PTK2 | 0.35425095 |
128 | CAMK1G | 0.35071763 |
129 | PRKCE | 0.35055274 |
130 | CAMKK1 | 0.34827033 |
131 | STK38L | 0.34641686 |
132 | MAP2K2 | 0.34489147 |
133 | PRKCQ | 0.33494305 |
134 | MAPKAPK3 | 0.32605581 |
135 | MAPK7 | 0.31971309 |
136 | MAP3K6 | 0.30702319 |
137 | MAP3K13 | 0.29322152 |
138 | CAMK2D | 0.29021525 |
139 | SCYL2 | 0.28164085 |
140 | MTOR | 0.27988145 |
141 | DMPK | 0.27654742 |
142 | EPHA3 | 0.27531923 |
143 | ILK | 0.27191445 |
144 | MAP3K2 | 0.26602325 |
145 | PRKACA | 0.26076039 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.93834270 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49494410 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17689629 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.05538025 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.99957180 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.89299641 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87687154 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82184574 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65265251 |
10 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.55802311 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55614385 |
12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.37412367 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34117015 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24316514 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23613175 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22454088 |
17 | * Peroxisome_Homo sapiens_hsa04146 | 2.07240275 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03675461 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02979631 |
20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.95016787 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77918643 |
22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77140645 |
23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.72239995 |
24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69640139 |
25 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63110546 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62945671 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58928464 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58496948 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58335667 |
30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.55089921 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55074274 |
32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.53937609 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53778356 |
34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53521832 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52041800 |
36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46293551 |
37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45511309 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43915332 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43568091 |
40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43496815 |
41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.42849520 |
42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42524466 |
43 | Bile secretion_Homo sapiens_hsa04976 | 1.38974892 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38654115 |
45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35234216 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34891040 |
47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32596147 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32071148 |
49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26214953 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24791880 |
51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23771375 |
52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20790005 |
53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20049896 |
54 | ABC transporters_Homo sapiens_hsa02010 | 1.12801575 |
55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12005425 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10578959 |
57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10064567 |
58 | Renin secretion_Homo sapiens_hsa04924 | 1.09410432 |
59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08086972 |
60 | Insulin secretion_Homo sapiens_hsa04911 | 1.00374370 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00229737 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99675794 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96313835 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95953989 |
65 | Lysine degradation_Homo sapiens_hsa00310 | 0.86866025 |
66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85861333 |
67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83780626 |
68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79580258 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78125575 |
70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77982864 |
71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73704934 |
72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73185491 |
73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67272894 |
74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63529194 |
75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63388877 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62662563 |
77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61383805 |
78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61099136 |
79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60655362 |
80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58112003 |
81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58005052 |
82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57664552 |
83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55274782 |
84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55227656 |
85 | Insulin resistance_Homo sapiens_hsa04931 | 0.52504090 |
86 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50743036 |
87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49599548 |
88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49155395 |
89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48269038 |
90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47961725 |
91 | Salivary secretion_Homo sapiens_hsa04970 | 0.47174904 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46876708 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46726593 |
94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.46465391 |
95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45118534 |
96 | Platelet activation_Homo sapiens_hsa04611 | 0.44969502 |
97 | Morphine addiction_Homo sapiens_hsa05032 | 0.44472689 |
98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43748697 |
99 | Tight junction_Homo sapiens_hsa04530 | 0.43104143 |
100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42764751 |
101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41094303 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40682742 |
103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38213657 |
104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37678912 |
105 | Taste transduction_Homo sapiens_hsa04742 | 0.37588202 |
106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37369444 |
107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37278173 |
108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35032796 |
109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31421222 |
110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31307223 |
111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30509265 |
112 | Prion diseases_Homo sapiens_hsa05020 | 0.24844647 |
113 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19241891 |
114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.18380978 |
115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17589641 |
116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16680133 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16477408 |
118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15489696 |
119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08903068 |
120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1261151 |
121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1248024 |
122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1245767 |
123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1000776 |
124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0971385 |
125 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0893951 |
126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0712273 |
127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0708829 |
128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0617645 |
129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0615132 |
130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0609171 |
131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0576836 |
132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0538388 |
133 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0470728 |
134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0358919 |
135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0319523 |